Announcement of TTY Biopharm's unaudited income information in January 2022
2022.2.16
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/02/16 | Time of announcement | 13:35:53 |
| Subject | Announcement of TTY Biopharm's unaudited income information in January 2022 | ||||
| Date of events | 2022/02/16 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2022/02/16 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $407,527 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $108,874 thousands, and a consolidated income before tax of $116,730 thousands in January 2022; net income attributed to stockholders of the parent company was $89,688 thousands; EPS is $0.36. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||